Breast lumps screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 22: | Line 22: | ||
*** Women with age> 40 years is recommended for clinical breast examination annually | *** Women with age> 40 years is recommended for clinical breast examination annually | ||
* [[Ultrasound]] | * [[Ultrasound]] | ||
** whole breast ultrasound detects lesions in dense breast tissue which could not be diagnosed by mammography <ref name="pmid19727744">{{cite journal| author=Kelly KM, Dean J, Comulada WS, Lee SJ| title=Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. | journal=Eur Radiol | year= 2010 | volume= 20 | issue= 3 | pages= 734-42 | pmid=19727744 | doi=10.1007/s00330-009-1588-y | pmc=2822222 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19727744 }} </ref> | ** whole breast [[ultrasound]] detects lesions in dense breast tissue which could not be diagnosed by [[mammography]] <ref name="pmid19727744">{{cite journal| author=Kelly KM, Dean J, Comulada WS, Lee SJ| title=Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. | journal=Eur Radiol | year= 2010 | volume= 20 | issue= 3 | pages= 734-42 | pmid=19727744 | doi=10.1007/s00330-009-1588-y | pmc=2822222 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19727744 }} </ref> | ||
*[[Mammography]]<ref name="pmid15282350">{{cite journal| author=Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al.| title=Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 5 | pages= 427-37 | pmid=15282350 | doi=10.1056/NEJMoa031759 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15282350 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=15656564 Review in: ACP J Club. 2005 Jan-Feb;142(1):23] </ref> | *[[Mammography]]<ref name="pmid15282350">{{cite journal| author=Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al.| title=Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 5 | pages= 427-37 | pmid=15282350 | doi=10.1056/NEJMoa031759 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15282350 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=15656564 Review in: ACP J Club. 2005 Jan-Feb;142(1):23] </ref> | ||
**Gold standard of screening | **Gold standard of screening | ||
| Line 28: | Line 28: | ||
**Regarding to 2013 NCCN guidelines annual screening in average risk women aged≥ 40 years | **Regarding to 2013 NCCN guidelines annual screening in average risk women aged≥ 40 years | ||
**Regarding to 2013 NCCN guidelines annual screening in high risk women from age of 25 years | **Regarding to 2013 NCCN guidelines annual screening in high risk women from age of 25 years | ||
**Sensitivity of 0.33-0.39 and specificity of 0.95 | **[[Sensitivity]] of 0.33-0.39 and [[specificity]] of 0.95 | ||
*[[Magnetic resonance imaging]]<ref name="pmid15282350">{{cite journal| author=Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al.| title=Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 5 | pages= 427-37 | pmid=15282350 | doi=10.1056/NEJMoa031759 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15282350 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=15656564 Review in: ACP J Club. 2005 Jan-Feb;142(1):23] </ref> <ref name="pmid18458280">{{cite journal| author=Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D| title=Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. | journal=Ann Intern Med | year= 2008 | volume= 148 | issue= 9 | pages= 671-9 | pmid=18458280 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18458280 }} </ref> | *[[Magnetic resonance imaging]]<ref name="pmid15282350">{{cite journal| author=Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al.| title=Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 5 | pages= 427-37 | pmid=15282350 | doi=10.1056/NEJMoa031759 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15282350 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=15656564 Review in: ACP J Club. 2005 Jan-Feb;142(1):23] </ref> <ref name="pmid18458280">{{cite journal| author=Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D| title=Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. | journal=Ann Intern Med | year= 2008 | volume= 148 | issue= 9 | pages= 671-9 | pmid=18458280 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18458280 }} </ref> | ||
**Significant method for detection, assessment and management of breast cancer | **Significant method for detection, assessment and management of [[breast cancer]] | ||
**Sensitivity of 0.77-0.79 and specificity of 0.86-0.89 | **[[Sensitivity]] of 0.77-0.79 and [[specificity]] of 0.86-0.89 | ||
** Based on 2013 NCCN guidelines annual MRI for individuals with > 20% risk of developing breast cancer in lifetime starting at age of 25 years | ** Based on 2013 NCCN guidelines annual [[MRI]] for individuals with > 20% risk of developing [[breast cancer]] in lifetime starting at age of 25 years | ||
** Beneficial modality in high risk individuals | ** Beneficial modality in high risk individuals | ||
** Valuable in individuals with equivocal results from other screening tests | ** Valuable in individuals with equivocal results from other screening tests | ||
**Usable for individuals with ineffective mammography results due to breast augmentation | **Usable for individuals with ineffective [[mammography]] results due to breast augmentation | ||
==References== | ==References== | ||
Revision as of 19:43, 7 December 2018
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps screening On the Web |
|
American Roentgen Ray Society Images of Breast lumps screening |
|
Risk calculators and risk factors for Breast lumps screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
The Screening methods of breast lesions[1]:
- Breast examination
- Self breast examination
- Although this is controversial, most clinicians recommend women to perform self examination monthly
- Clinical breast examination
- Women with age> 40 years is recommended for clinical breast examination annually
- Self breast examination
- Ultrasound
- whole breast ultrasound detects lesions in dense breast tissue which could not be diagnosed by mammography [2]
- Mammography[3]
- Gold standard of screening
- Early detection of non-palpabale masses
- Regarding to 2013 NCCN guidelines annual screening in average risk women aged≥ 40 years
- Regarding to 2013 NCCN guidelines annual screening in high risk women from age of 25 years
- Sensitivity of 0.33-0.39 and specificity of 0.95
- Magnetic resonance imaging[3] [4]
- Significant method for detection, assessment and management of breast cancer
- Sensitivity of 0.77-0.79 and specificity of 0.86-0.89
- Based on 2013 NCCN guidelines annual MRI for individuals with > 20% risk of developing breast cancer in lifetime starting at age of 25 years
- Beneficial modality in high risk individuals
- Valuable in individuals with equivocal results from other screening tests
- Usable for individuals with ineffective mammography results due to breast augmentation
References
- ↑ Shah R, Rosso K, Nathanson SD (2014). "Pathogenesis, prevention, diagnosis and treatment of breast cancer". World J Clin Oncol. 5 (3): 283–98. doi:10.5306/wjco.v5.i3.283. PMC 4127601. PMID 25114845.
- ↑ Kelly KM, Dean J, Comulada WS, Lee SJ (2010). "Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts". Eur Radiol. 20 (3): 734–42. doi:10.1007/s00330-009-1588-y. PMC 2822222. PMID 19727744.
- ↑ 3.0 3.1 Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM; et al. (2004). "Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition". N Engl J Med. 351 (5): 427–37. doi:10.1056/NEJMoa031759. PMID 15282350. Review in: ACP J Club. 2005 Jan-Feb;142(1):23
- ↑ Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008). "Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer". Ann Intern Med. 148 (9): 671–9. PMID 18458280.